Ledger.Open graph →
SEC Form D · filed November 17, 2014

Amarantus Bioscience Holdings, Inc

Offering
$3.0M
Sold
$3.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
SAN FRANCISCO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (16)

John Commissiong · San Francisco, CAExec · DirectorRobert Farrell · San Francisco, CAExecRobert Harris · BROOKLYN, NYDirectorGerald Commissiong · San Francisco, CAExec · DirectorDonald Huffman · Fremont, CADirectorMarc Faerber · San Francisco, CAExecIain Ross · San Francisco, CADirectorDavid Lowe · San Diego, CADirectorJohn Commissiong · San Francisco, CAExec · DirectorRobert Farrell · San Francisco, CAExecRobert Harris · San Francisco, CADirectorGerald Commissiong · San Francisco, CAExec · DirectorDonald Huffman · San Francisco, CADirectorMarc Faerber · San Francisco, CAExecIain Ross · San Francisco, CADirectorDavid Lowe · Austin, TXDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗